Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients
Condition(s):Fatty Liver DiseaseLast Updated:January 23, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Fatty Liver DiseaseLast Updated:January 23, 2023Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 18, 2023Not yet recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 14, 2022Recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:February 21, 2023Recruiting
Condition(s):Liver SteatosesLast Updated:August 15, 2023Recruiting
Condition(s):Nonalcoholic Fatty Liver Disease; Type 2 Diabetes MellitusLast Updated:October 5, 2023Recruiting
Condition(s):Heart Failure With Preserved Ejection Fraction; Non Alcoholic Fatty LiverLast Updated:April 21, 2023Not yet recruiting
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:August 10, 2022Not yet recruiting
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:April 10, 2023Recruiting
Condition(s):Fatty LiverLast Updated:November 21, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.